Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Continuous activity of significant antibiotics.

E Bergogne-Bérézin1

  • 1Department of Microbiology, Bichat University Hospital, Paris, France.

Clinical Therapeutics
|January 1, 1991
PubMed
Summary

Antibiotic resistance in respiratory tract infections (RTIs) has limited the effectiveness of older drugs. Newer antibiotics and combination therapies are now crucial for treating community-acquired RTIs, considering cost-effectiveness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cefuroxime: pharmacokinetic study in bronchial secretions.

Proceedings of the Royal Society of Medicine·2010
Same author

[After the "era of antibiotics", the "era of resistance"].

Presse medicale (Paris, France : 1983)·2004
Same author

[Pharmacologic innovations, the fluoroquinolone model].

Presse medicale (Paris, France : 1983)·2003
Same author

[Anti-infective agents and bacterial resistance, monitor, eradicate or avoid resistance?].

Presse medicale (Paris, France : 1983)·2002
Same author

[Latest news on fluoroquinolones].

Presse medicale (Paris, France : 1983)·2002
Same author

[Drawbacks and problems of infectiology today].

Presse medicale (Paris, France : 1983)·2002

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Microbiology

Background:

  • Respiratory tract infections (RTIs) are a leading reason for antibiotic prescriptions in primary care.
  • The efficacy of early antibiotics like penicillin was short-lived due to rapid development of resistant bacterial strains.

Purpose of the Study:

  • To review the historical use of antibiotics for community-acquired RTIs.
  • To examine the emergence of antibiotic resistance in common respiratory pathogens.
  • To discuss the development and current considerations for RTI antibiotic therapy.

Main Methods:

  • Literature review of antibiotic usage and resistance patterns for RTIs.
  • Analysis of historical data on antibiotic susceptibility of respiratory pathogens.
  • Examination of the evolution of antibiotic classes and resistance mechanisms.

Main Results:

  • Penicillin's effectiveness was quickly diminished by resistant organisms.
  • Resistance to macrolides, tetracyclines, and co-trimoxazole affects up to 30% of pneumococcal and streptococcal strains.
  • Increasing resistance to ampicillin and amoxicillin due to beta-lactamase production in Haemophilus species and Moraxella catarrhalis has been observed.

Conclusions:

  • The emergence of resistant bacteria necessitates the development of new antibiotic agents.
  • Advanced antibiotics like amoxicillin + clavulanic acid and cefaclor offer improved stability against bacterial resistance mechanisms.
  • Current treatment strategies for RTIs must balance efficacy with cost-effectiveness.

Related Experiment Videos